Yanlin Yang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Computed Tomography

Diffusion Weighted

Sentinel Lymph Node

Neoadjuvant Chemotherapy

Top Venues

Journal of cancer research and clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yanlin Yang, Haoru Wang, Jiajun Si, Li Zhang, Hao Ding, Fang Wang, Ling He, Xin Chen
Predicting response of hepatoblastoma primary lesions to neoadjuvant chemotherapy through contrast-enhanced computed tomography radiomics. Journal of cancer research and clinical oncology 150 (5) (2024)
Yanlin Yang, Haoru Wang, Jiajun Si, Li Zhang, Hao Ding, Fang Wang, Ling He, Xin Chen
Predicting response of hepatoblastoma primary lesions to neoadjuvant chemotherapy through contrast-enhanced computed tomography radiomics. Journal of cancer research and clinical oncology 150 (5) (2024)
Yanlin Yang, Haoru Wang, Jiajun Si, Li Zhang, Hao Ding, Fang Wang, Ling He, Xin Chen
Predicting response of hepatoblastoma primary lesions to neoadjuvant chemotherapy through contrast-enhanced computed tomography radiomics. Journal of cancer research and clinical oncology 150 (5) (2024)
Yanlin Yang, Haoru Wang, Jiajun Si, Li Zhang, Hao Ding, Fang Wang, Ling He, Xin Chen
Predicting response of hepatoblastoma primary lesions to neoadjuvant chemotherapy through contrast-enhanced computed tomography radiomics. Journal of cancer research and clinical oncology 150 (5) (2024)
Yanlin Yang, Haoru Wang, Jiajun Si, Li Zhang, Hao Ding, Fang Wang, Ling He, Xin Chen
Predicting response of hepatoblastoma primary lesions to neoadjuvant chemotherapy through contrast-enhanced computed tomography radiomics. Journal of cancer research and clinical oncology 150 (5) (2024)
Yanlin Yang, Haoru Wang, Jiajun Si, Li Zhang, Hao Ding, Fang Wang, Ling He, Xin Chen
Predicting response of hepatoblastoma primary lesions to neoadjuvant chemotherapy through contrast-enhanced computed tomography radiomics. Journal of cancer research and clinical oncology 150 (5) (2024)